2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe
Makaleler > Tam Makale · 2022
Yazarlar: Richard Graham, Ana P. Moreira, Andor W. J. M. Glaudemans, Lars Thorbjørn Jensen, Jasna Mihaïlovic, Sergei Nazarenko, Zehra ÖZCAN, Doina Piciu, Wolfgang Wadsak, Jolanta Kunikowska, François Jamar
European Journal of Nuclear Medicine and Molecular Imaging, Uluslararası, Wos, 2022, cilt 49, ss 3309-3315
DOI: 10.1007/s00259-022-05881-y
Özet
The COVID-19 pandemic not only affected our daily lives, but also changed the work environment. Significant adjustments had to be taken in our nuclear medicine departments. To report this impact, one year ago, the results of a first survey conducted by the EANM were published, describing the reduction of conventional diagnostic and therapeutic procedures for benign diseases, while the number of diagnostic PET/CT scans and therapeutic procedures for malignancy remained stable [ 1 ]. Following on from this 2021 survey, a subsequent survey was undertaken which closed in February 2022, also now with special attention for research and education. This web-based survey included closed-ended questions and free comments on clinical activity, organisation of departments, research and publications, and education (including virtual offerings) (Table 1 ).